Cabaletta Bio Inc
CABA
Get informed when a big investor buys or sells
+ FollowMarket Cap$415.79M
Close$
$0.55
74.6% downside
Current Fair Value
74.6% downsideOvervalued by 74.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $415.79 Million |
|---|---|
| Enterprise Value | $216.40 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.64 |
| Beta | 3.26 |
| Outstanding Shares | 151,160,280 |
Return
| Return on Equity | -86.10% |
|---|---|
| Return on Assets | -70.63% |
| Return on Invested Capital | -86.17% |
Valuation & Multiples
| P/E Ratio | -1.61 |
|---|---|
| PEG | -12.37 |
| Price to Sales | - |
| Price to Book Ratio | 2.16 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0501▼ 1.58% |
|---|---|
| Total Calls | 4,518,100▲ 102.90% |
| Total Puts | 226,200▲ 54.19% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 104.69%▲ 29.10% |
|---|---|
| Total Invested | $491.61M▲ 116.08% |
| Investors Holding | 151▲ 33.00% |
ESG Score
No data